Cargando…
Mevalonate Kinase Deficiency and Squalene Synthase Inhibitor (TAK-475): The Balance to Extinguish the Inflammation
Mevalonate Kinase Deficiency (MKD) is a rare inborn disease belonging to the family of periodic fever syndromes. The MKD phenotype is characterized by systemic inflammation involving multiple organs, including the nervous system. Current anti-inflammatory approaches to MKD are only partially effecti...
Autores principales: | Rimondi, Erika, Valencic, Erica, Tommasini, Alberto, Secchiero, Paola, Melloni, Elisabetta, Marcuzzi, Annalisa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8533390/ https://www.ncbi.nlm.nih.gov/pubmed/34680069 http://dx.doi.org/10.3390/biom11101438 |
Ejemplares similares
-
Anti-inflammatory and cytoprotective effects of a squalene synthase inhibitor, TAK-475 active metabolite-I, in immune cells simulating mevalonate kinase deficiency (MKD)-like condition
por: Suzuki, Nobutaka, et al.
Publicado: (2016) -
Prenylation Defects and Oxidative Stress Trigger the Main Consequences of Neuroinflammation Linked to Mevalonate Pathway Deregulation
por: Pisanti, Simona, et al.
Publicado: (2022) -
To Extinguish the Fire from Outside the Cell or to Shutdown the Gas Valve Inside? Novel Trends in Anti-Inflammatory Therapies
por: Marcuzzi, Annalisa, et al.
Publicado: (2015) -
Autoinflammatory Diseases and Cytokine Storms—Imbalances of Innate and Adaptative Immunity
por: Marcuzzi, Annalisa, et al.
Publicado: (2021) -
Role of vitamin D in the pathogenesis of atheromatosis
por: Rimondi, Erika, et al.
Publicado: (2021)